User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 6 results.
    • Speech
    Partial CRISPR/Cas9 IL1R1 & IFNGR1 Knock-Down Improves β-cell Survival And Function Under Cytokine-Induced Inflammation
    Daems, Caroline[UCL] Vanderroost, Juliette[UCL] Sokal, Etienne[UCL] Lysy, Philippe[UCL] (2021) 49th Annual Congress of BSP/BVK: The changing faces of pediatrics, virtual congress — WEBINAR
    • Journal article
    Diabète de type 1 :une maladie auto-immune, vraiment?
    Daems, Caroline[UCL] Vanderroost, Juliette[UCL] Lysy, Philippe[UCL] (2019) Louvain médical — Vol. 138, no.4, p. 185-192 (2019)
    • Speech
    Empagliflozin And GABA Improve β-Cell Mass And Glucose Tolerance In New-Onset Type 1 Diabetes
    Daems, Caroline[UCL] Welsch, Sophie[UCL] Boughaleb, Hasnae[UCL] Vanderroost, Juliette[UCL] Robert, Annie[UCL] Sokal, Etienne[UCL] Lysy, Philippe[UCL] (2019) 58th Annual ESPE meeting (European Society for Paediatric Endocrinology) — Vienne, Autriche
    • Journal article
    Early Treatment with Empagliflozin and GABA Improves -Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice.
    Daems, Caroline[UCL] Welsch, Sophie[UCL] Boughaleb, Hasnae[UCL] Vanderroost, Juliette[UCL] Robert, Annie[UCL] Sokal, Etienne[UCL] Lysy, Philippe[UCL] (2019) Journal of diabetes research — Vol. 2019, p. 2813489 [1-14] (2019)
    • Speech
    Empagliflozin And GABA Improve β-Cell Mass And Glucose Tolerance In New-Onset Type 1 Diabetes
    Daems, Caroline[UCL] Welsch, Sophie[UCL] Boughaleb, Hasnae[UCL] Vanderroost, Juliette[UCL] Robert, Annie[UCL] Sokal, Etienne[UCL] Lysy, Philippe[UCL] (2019) ATDD (Advances Technologies and Treatments for Diabetes — Berling, Allemagne
    • Speech
    Partial CRISPR/Cas9 IL1R1 & IFNGR1 Knock-Down Improves β-cell Survival And Function Under Cytokine-Induced Inflammation
    Daems, Caroline[UCL] Vanderroost, Juliette[UCL] Sokal, Etienne[UCL] Lysy, Philippe[UCL] (2019) European Society of Pediatric Endocrinology (ESPE) — Vienne, Autriche